RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia

Authors
Publication date
17 November 2020
Publisher
Springer Nature [academic journals on nature.com]

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Supporting member

    Queen Mary Research Online

    redirect
    oaioai:qmro.qmul.ac.uk:123456789/...
    Last time updated on 22/11/2020